Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Autologous Peripheral Blood CD34 Stem Cell Implantation in Chronic Stroke Patients

NCT00950521 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00950521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00950521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Autologous Peripheral Blood CD34 Stem Cell Implantation in Chronic Stroke Patients
Lead sponsor
China Medical University Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2009
Completion date
December 31, 2010
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

middle cerebral artery infarction, stroke